Williams v. Horizon Therapeutics USA, Inc.
| Cynthia Williams |
| Horizon Therapeutics USA, Inc. |
| 1:2022cv06838 |
| December 6, 2022 |
| US District Court for the Northern District of Illinois |
| Robert W Gettleman |
| Matthew F Kennelly |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 3, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 23 NOTICE by Eric Anthony Riegner of Change of Address (Riegner, Eric) |
| Filing 22 MINUTE entry before the Honorable Matthew F. Kennelly: Telephonic motion hearing held on 1/30/2023. The telephonic status hearing set for 2/6/2023 is vacated and reset to 2/22/2023 at 9:15 a.m. The following call-in number will be used for the hearing: 888-684-8852, access code 746-1053. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice. (mma, ) |
| Filing 21 STATUS Report Joint Initial Status Report by Horizon Therapeutics USA, Inc. (Riegner, Eric) |
| Filing 20 MINUTE entry before the Honorable Matthew F. Kennelly: Defendant's motion to dismiss #18 is set for a telephonic hearing on 1/30/2023 at 8:55 AM. Plaintiff should be prepared to advise the Court whether plaintiff wishes to amend the complaint to attempt to deal with some or all of the issues raised in the motion to dismiss or instead wishes to respond to the motion. (mk) |
| Filing 19 MEMORANDUM by Horizon Therapeutics USA, Inc. in support of motion to dismiss #18 (Attachments: #1 Exhibit A - FDA BLA Approval for TEPEZZA, #2 Exhibit B - FDA-Approved labeling for TEPEZZA, #3 Exhibit B - FDA-Approved labeling for TEPEZZA)(Riegner, Eric) |
| Filing 18 MOTION by Defendant Horizon Therapeutics USA, Inc. to dismiss (Riegner, Eric) |
| Filing 17 MINUTE entry before the Honorable Matthew F. Kennelly: Defendant's motion for leave to file excess pages #16 is granted, but only in part. Defendant's opening memorandum in support of its motion to dismiss may be up to 20 pages long. (mk) |
| Filing 16 MOTION by Defendant Horizon Therapeutics USA, Inc. for leave to file excess pages as to Memorandum in Support of Motion to Dismiss (Riegner, Eric) |
| Filing 15 Attorney Appearance by Horizon Therapeutics USA, Inc. (O'Carroll, Thomas) |
| Filing 14 MINUTE entry before the Honorable Matthew F. Kennelly: Unopposed motion for extension of time #10 is granted; response to complaint is to be filed by 1/25/2023. (mk) |
| Filing 13 MINUTE entry before the Honorable Matthew F. Kennelly: By no later than 1/30/2023, the parties (or, if no defendant has yet appeared, the plaintiff(s)) are to file a joint status report that includes the following information: (1) the status of service of process upon each defendant; (2) a description of each party's claims and defenses; (3) details regarding any discussions concerning settlement, whether before or after the filing of the lawsuit; (4) a proposed discovery and pretrial schedule; and (5) any other matters that any party wishes to bring to the Court's attention. The case is set for a case management conference under Federal Rule of Civil Procedure 16 on 2/6/2023 at 8:55 a.m. The case management conference will be conducted by telephone, using the following call-in number: 888-684-8852, access code 746-1053. Plaintiff's counsel is directed to provide a copy of this order to any defendant that has not yet appeared by counsel via regular mail at the address at which the defendant has been or is to be served with process. (mk) |
| Filing 12 ANNUAL REMINDER: Pursuant to #Local Rule 3.2 (Notification of Affiliates)#, any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this #LINK# will provide additional information. Signed by the Executive Committee on 12/29/2022: Mailed notice. (tg, ) |
| Filing 11 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Horizon Therapeutics USA, Inc. (McGrath, Daniel) |
| Filing 10 MOTION by Defendant Horizon Therapeutics USA, Inc. for extension of time to file answer or otherwise plead (Riegner, Eric) |
| Filing 9 ATTORNEY Appearance for Defendant Horizon Therapeutics USA, Inc. by Daniel William McGrath corrected (McGrath, Daniel) |
| Filing 8 ATTORNEY Appearance for Defendant Horizon Therapeutics USA, Inc. by Lori Elizabeth Hammond (Hammond, Lori) |
| Filing 7 ATTORNEY Appearance for Defendant Horizon Therapeutics USA, Inc. by Eric Anthony Riegner (Riegner, Eric) |
| Filing 6 ATTORNEY Appearance for Defendant Horizon Therapeutics USA, Inc. by Daniel William McGrath (McGrath, Daniel) |
| Filing 5 EXECUTIVE COMMITTEE ORDER: Case reassigned to the Honorable Matthew F. Kennelly for all further proceedings. Honorable Robert W. Gettleman no longer assigned to the case. Signed by Executive Committee on 12/8/22. (nsf, ) |
| Filing 4 ATTORNEY Appearance for Plaintiff Cynthia Williams by Timothy J. Becker (Becker, Timothy) |
| Filing 3 ATTORNEY Appearance for Plaintiff Cynthia Williams by Stacy Kathryn Hauer (Hauer, Stacy) |
| Filing 2 CIVIL Cover Sheet (Hauer, Stacy) |
| Filing 1 COMPLAINT filed by Cynthia Williams; Jury Demand. Filing fee $ 402, receipt number AILNDC-20110943.(Hauer, Stacy) |
| CASE ASSIGNED to the Honorable Robert W. Gettleman. Designated as Magistrate Judge the Honorable Beth W. Jantz. Case assignment: Random assignment. (emc, ) |
| SUMMONS Issued as to Defendant Horizon Therapeutics USA, Inc. (emc, ) |
| CLERK'S NOTICE: Pursuant to Local Rule 73.1(b), a United States Magistrate Judge of this court is available to conduct all proceedings in this civil action. If all parties consent to have the currently assigned United States Magistrate Judge conduct all proceedings in this case, including trial, the entry of final judgment, and all post-trial proceedings, all parties must sign their names on the attached #Consent To# form. This consent form is eligible for filing only if executed by all parties. The parties can also express their consent to jurisdiction by a magistrate judge in any joint filing, including the Joint Initial Status Report or proposed Case Management Order. (emc, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
